BioSpace News Archive

Digital integration allows members to seamlessly switch to PillPack for their pharmacy needs

Imperative Care, Inc. today announced that it has completed the initial closing of a Series C financing of $85 million to support the commercial launch of the company’s portfolio, which is composed of the latest advances in neurovascular devices treating ischemic and hemorrhagic strokes.

Aro Biotherapeutics Company announces that Scott Greenberg has joined the company as Vice President, Business Development and Alliance Management.

Significant milestone reached in 2019 with additional patent applications approved in three countries

Exagen Inc. announced that it has formed a Scientific Advisory Board consisting of national experts in the clinical management of rheumatic autoimmune diseases including rheumatoid arthritis and lupus.

Saebo’s flagship product, SaeboFlex, included in the newly created Medicine Wellcome Galleries revealing break-through medical treatment innovations spanning the last 500 years.

Progenity, a privately held biotechnology company, and Geisinger, one of the nation’s most innovative health services organizations, announced publication of a study in Obstetrics & Gynecology demonstrating the significant economic burden associated with preeclampsia.

Delivering the Largest Commercially Available Collection of Pathologist‑Verified Antibodies for Imaging Mass Cytometry

ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that it has completed the development process and submitted a Letter to the Design History File and updated the device listing with the U.S. Food and Drug Administration (FDA) for the PXP®-1000 System.

Separate data demonstrated that finding mutations that increase risks for breast cancer frequently led clinicians to change their medical recommendations to patients.